BioPharm International
BioPharm International-09-15-2004
Volume: 2004 Supplement
Issue: 3
BioPharm International-08-01-2004
Volume: 17
Issue: 8
BioPharm International-08-15-2004
Volume: 2004 Supplement
Issue: 2
BioPharm International-07-01-2004
Volume: 17
Issue: 7
BioPharm International-06-01-2004
Volume: 17
Issue: 6
BioPharm International-05-01-2004
Volume: 17
Issue: 5
BioPharm International-04-01-2004
Volume: 17
Issue: 4
BioPharm International-03-01-2004
Volume: 17
Issue: 3
BioPharm International-02-01-2004
Volume: 17
Issue: 2
BioPharm International-02-15-2004
Volume: 2004 Supplement
Issue: 1
BioPharm International-01-01-2004
Volume: 17
Issue: 1
BioPharm International-12-01-2003
Volume: 16
Issue: 12
BioPharm International-11-15-2003
Volume: 2003 Supplement
Issue: 4
BioPharm International-11-01-2003
Volume: 16
Issue: 11
BioPharm International-10-01-2003
Volume: 16
Issue: 10
BioPharm International-09-01-2003
Volume: 16
Issue: 9
BioPharm International-09-15-2003
Volume: 2003 Supplement
Issue: 3
BioPharm International-08-01-2003
Volume: 16
Issue: 8
BioPharm International-07-01-2003
Volume: 16
Issue: 7
BioPharm International-07-15-2003
Volume: 2003 Supplement
Issue: 2
BioPharm International-06-01-2003
Volume: 16
Issue: 6
BioPharm International-06-02-2003
Volume: 2003 Supplement
Issue: 1
BioPharm International-05-01-2003
Volume: 16
Issue: 5
BioPharm International-04-01-2003
Volume: 16
Issue: 4
BioPharm International-03-01-2003
Volume: 16
Issue: 3
BioPharm International-02-01-2003
Volume: 16
Issue: 2
BioPharm International-01-01-2003
Volume: 16
Issue: 1
BioPharm International-12-15-2002
Volume: 15
Issue: 1
BioPharm International-11-01-2002
Volume: 15
Issue: 11
BioPharm International-10-01-2002
Volume: 15
Issue: 10
Advertisement
Advertisement
Trending on BioPharm International
1
How CDMO Alliances Can Provide End-to-End Service that Reduces Drug Development Time and Costs
2
FDA Clears PharmaResearch IND for Nano-Based Cancer Drug PRD-101
3
First-in-Human Study Validates Safety of Next-Generation mRNA–LNP Platform
4
Industry Outlook 2026: Key Forces Transforming Drug Pipelines (Part 2)
5